An interventional study of ketogenic nutritional Supplement and non-ketogenic, isocaloric control in Overweight and Obesity, sponsored by Maastricht University Medical Center. Recruiting at 1 site in Netherlands. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-09.
Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Obesity by Maastricht University Medical Center — 4 open to participants now, 4 under way, none of them phase 3. Obesity · Maastricht University Medical Center.
Among the 75 studies in Obesity by Maastricht University Medical Center, this one is the 58th largest by planned enrollment of the 67 interventional ones that give a count, is one of 2 that started in 2025, is one of 65 with no phase, and was the 73rd registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →4 of the 75 studies in Obesity by Maastricht University Medical Center are open now, in 1 country. Recruiting first, the newest first:
Maastricht University Medical Center · Sites in Netherlands
Ages 20–70 · Healthy volunteers
Maastricht University Medical Center · Sites in Netherlands
Ages 40–75 · Healthy volunteers
Maastricht University Medical Center · Sites in Netherlands
Ages 40–75
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 60 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 14 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 40 across the 67 interventional studies, 91 across the 8 observational. Of the 60 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Maastricht University Medical Center is the lead sponsor of 854 studies on the registry; 114 are open to participants now.
2 of the studies in Obesity by Maastricht University Medical Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06923644Maastricht University Medical CenterTargeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases | 2027-04 |
| NCT07395973Maastricht University Medical CenterThe Effects of a 4-week Supplementation With a Ketogenic Nutrient Mix on 24-hour Substrate Metabolism and Muscle Health | 2027-10-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 75 studies in Obesity by Maastricht University Medical Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will investigate the effect of providing a daily ketogenic nutritional supplement in the evening for a prolonged time (4 weeks) to induce a mild ketogenic state during the night in healthy elderly (60-80 years), overweight/obese (BMI: 25-35 kg/m2) individuals with low physical activity, on 24h rhythmicity in energy metabolism as compared to a non-ketogenic, isocaloric control.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's planned enrollment of 14 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →Maastricht University Medical Center is the lead sponsor of 854 studies on the registry; 114 are open to participants now.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Daily ketogenic nutritional supplement for 4 weeks
Dietary Supplement: ketogenic nutritional Supplement
Daily control for 4 weeks
Dietary Supplement: non-ketogenic, isocaloric control
Daily ketogenic nutritional supplement for 4 weeks
Daily control for 4 weeks
Delta respiratory exchange ratio (from 23:00 till 04:00)
Measured with indirect calorimetry
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Skeletal mitochondrial function
Measured in muscle biopsy
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Protein and gene markers of skeletal muscle metabolism
Measured in muscle biopsy
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Metabolic blood markers
Measured in blood samples
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Interstitial ketone levels
Measured with a continuous ketone monitor
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Interstitial glucose levels
Measured with a continuous glucose monitor
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Whole body substrate utilization
Measured with indirect calorimetry
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Whole body energy expenditure
Measured with indirect calorimetry
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Physical performances
Measured with 6-minute walk test, chair-stand-test, and handgrip strength test
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Cognitive performance
Measured using Cambridge Neuropsychological Test Automated Battery (CANTAB) and cerebral perfusion measured with transcranial doppler ultrasound
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Other perceivable benefits: microvasculature
Measured with retinal images
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Other perceivable benefits: sleep quality
Measured with sleep quality questionnaires
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Body composition
Measured with BodPod
Time frame: Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control
Started Nov 2025 (actual). Primary completion is estimated for Oct 2027, 23 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 23 months is close to that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Maastricht University Medical Center →